🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

3 people followed me and one person unfollowed me // automatically checked by fllwrs.com

Emerging Clinical Decision-Making Tools in Clinical Stage I and IIA/B Germ Cell Tumors—What Are the Targets? dailynews.ascopubs.org/do/emerging-cl…

Emerging Clinical Decision-Making Tools in Clinical Stage I and IIA/B Germ Cell Tumors—What Are the Targets? ASCO Daily News piece out today with colleagues Lucia Nappi Sia Daneshmand, M.D. and C. Kollmannsberger

Emerging Clinical Decision-Making Tools in Clinical Stage I and IIA/B Germ Cell Tumors—What Are the Targets? dailynews.ascopubs.org/do/emerging-cl…

3 people followed me // automatically checked by fllwrs.com

AUA Abstracts are out. Expanding data sets for surgical management of CSII GCT Sia Daneshmand, M.D., USC superstar young urologists and the whole network

Well, we will have at least one oral presentation at big #ASCO2023. Magnifico! Lucia Nappi

one person unfollowed me // automatically checked by fllwrs.com

Remember this is PFS or TFS NOT OS which is 100%

Nice AUA abstract by Candelas-Gomez, Hamilton, Jewett et al re Canadian 2nd opinion in GCT. Mirrors England SWENTOTECA German efforts at hub and spoke care delivery

one person followed me // automatically checked by fllwrs.com

Notified that S1823 will be presented as a poster in the Trials in Progress section #ASCO23. SWOG Cancer Research Network The Hope Foundation for Cancer Research Sia Daneshmand, M.D., Scott Eggener,Nabil Adra Lucia Nappi,Rob Hamilton DrBagrodia and Andrea Harzstark, SWOG biostats and the over 700 pts enrolled

Took Bard out for a spin. Not so impressive. Could not stage testis cancer and could not identify Larry Einhorn. Needs some work

3 people followed me // automatically checked by fllwrs.com

While not a lot of new information, the article is important in that it reiterates the high baseline of CVD risk factors (with or without cisplatin) for men as they move into their 40s/ 50s. Should have low threshold for management of HTN, dyslipidemia, obesity, energy balance

Well. . . This is a bit awkward. ChatGPT appears to be as good at poetry as it is at understanding clinical trial design, conduct, actual patient impact and cogent debate

Testis cancer oral abstracts ASCO pick up nicely on two emerging likely practice changing themes. miR371 (Lucia Nappi) and primary RPLND in early regional seminoma (T. Tandstad). Can't wait

Case for pRPLND as chemo-sparing approach in CSII NS becoming stronger. Ahmad Mousa Rob Hamilton #AUA2023 PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION FOR METASTATIC NONSEMINOMATOUS GERM CELL TUMOR:

JCO Comments and Controversies piece out. Provides rationale for PRESTIGE and MAGESTIC trials to come. Thanks Muhannad Alsyouf Sia Daneshmand, M.D. Lucia Nappi DOI: 10.1200/JCO.22.02002

Laura Caba Scott Eggener Matt Cooperberg Brian F. Chapin Sima Porten Kristen R. Scarpato Marc Dall'Era Daniel Lin Todd 〽️ Morgan, MD Alexander Kutikov MD Anne Schuckman Peter Black Daniel Barocas Stacy Loeb, MD Benjamin J. Davies MD Dave Penson Christopher J. Kane @RobertReiterMD Surena F Matin MD Willamette!!